Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant.
BACKGROUND
We compared, in patients contraindicated for kidney transplant, outcomes between those patients who were only on hemodialysis (HD) and those who were given peritoneal dialysis (PD) as first renal replacement therapy (RRT).


METHODS
Prospective, population-based cohort study of incident cases of end-stage renal disease between June 1997 and June 1999.


METHODS
A network of dialysis care: NEPHROLOR, that is, all the renal units in Lorraine, one of the 22 French administrative regions (population over 2.3 million people).


METHODS
387 patients were contraindicated for kidney transplant during the first 2 years of RRT: 284 were on HD, 103 on PD. Mean age was 67.6 +/- 11.3 years for HD patients and 70.8 +/- 11.4 years for PD patients (p = 0.015).


METHODS
Mortality until June 2003, hospitalization over the 2 first years of RRT, and Kidney Disease and Quality of Life Short Form (KDQOL-SF) 6 and 12 months after initiation of RRT.


RESULTS
HD patients were more likely to die from cardiac or cerebrovascular causes, PD from cachexia or withdrawal from dialysis. Whatever mode of RRT, the unadjusted 2-year and 5-year survival rates were similar (p = 0.98). The rate of total duration of hospital stay per month of RRT was similarin HD and PD groups: 2.7 +/- 4.5 and 2.9 +/- 4.2 days respectively (p = 0.7). PD was associated with better quality of life than HD. The dimensions Role limitation due to emotional function, Burden of kidney disease, and Role limitation due to physical function ranked first, second, and third for PD.


CONCLUSIONS
In Lorraine, end-stage renal disease patients who were given PD as first-line RRT had no excess of death risk or hospitalizations, and better quality of life the first year of RRT.
Frimat
Luc
L
Department of Nephrology, University Hospital of Nancy, France. L.frimat@chu-nancy.fr
Durand
Pierre-Yves
PY
Loos-Ayav
Carole
C
Villar
Emmanuel
E
Panescu
Victor
V
Briançon
Serge
S
Kessler
Michèle
M
D000368:Aged; D000075202:Contraindications; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D010530:Peritoneal Dialysis; D011446:Prospective Studies; D006435:Renal Dialysis; D016896:Treatment Outcome